Activated protein C resistance assay when applied in the general population

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 2, 1997, Pages 358-359

  Altes, A ^a   Souto, J C ^a   Mateo, J ^a   Borrell, M ^a   Fontcuberta, J ^a  

^a Hospital Esperit Sant   (Spain)

Author keywords

Activated protein C resistance; factor V Leiden; oral contraceptives; thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; THROMBOEMBOLISM;

EID: 0031025885     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70498-8     Document Type: Article

References (2)

1. M Hellgren PJ Svensson B Dahlbäck Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives Am J Obstet Gynecol 173 1995 210 213
2. FR. Rosendaal Oral contraceptives and screening for factor V Leiden Thromb Haemost 75 1996 520 526